BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:53 PM
 | 
May 31, 2007
 |  BC Extra  |  Clinical News

Ista reports ecabet Phase IIb results

ISTA reported preliminary results on three of four primary endpoints from a Phase IIb trial of ecabet to treat dry eye syndrome. The compound significantly improved Ocular Symptom Disease Index...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >